Suggested Topics within your search.
Suggested Topics within your search.
-
10101
-
10102
-
10103
-
10104
-
10105
-
10106
-
10107
-
10108
-
10109
-
10110
-
10111
-
10112
-
10113
Effect of planned visual education on university students’ attitudes and beliefs regarding skin cancer: a cluster-randomized controlled trial
Published 2025-05-01“…Therefore, raising public awareness through education is essential. OBJECTIVE: This study aimed to evaluate the effect of a planned visual education program—based on the Health Belief Model—on university students’ attitudes and beliefs regarding skin cancer. …”
Get full text
Article -
10114
Risk prediction model for poor prognosis after intravenous thrombolysis among ischemic stroke patients aged ≥ 80 years and analysis of follow-up
Published 2025-01-01“…An online prognostic calculator was developed.2.There was no further improvement in mRS Score in the elderly group after 180days (P < 0.05). (1)The prediction model can estimate the poor outcome of patients aged ≥ 80 years with acute ischemic stroke after intravenous alteplase thrombolysis.The predictors are readily derived at admission.The prediction calculator( https://80ivtr.shinyapps.io/dynnomapp/ ) can be used as a popular tool for physicians. (2)The total duration of benefit after intravenous thrombolysis for patients aged ≥ 80 years is 180 days, while it is at least 1 year for patients between 60 and 79 years.…”
Get full text
Article -
10115
-
10116
Development and validation of an improved prediction model for vaginal birth after previous cesarean section: a retrospective cohort study of a Chinese population
Published 2025-12-01“…Internal validation performed by bootstrap resampling, calibration curves, and Hosmer-Lemeshow test confirmed the model’s robust performance. An optimal predicted probability cut-off of 0.7 was identified by decision curve analysis and clinical considerations.Conclusions The improved predictive VBAC model exhibited adequate performance such that women with a prior low transverse cesarean delivery who scored 0.7 or higher (in the model-derived probability score) would consider TOLAC, potentially leading to a reduction in maternal-neonatal morbidity.Registration The study was approved by the Ethical Committee of Obstetrics and Gynecology Hospital, Fudan University (2018-43) and was registered in the Chinese Clinical Trial Registry (ChiCTR1900022484), https://www.chictr.org.cn/showproj.html?…”
Get full text
Article -
10117
-
10118
-
10119
-
10120